Fertilizers · Founded 1943 · www.fact.co.in · BSE 590024 · NSE FERT CHE(PS · ISIN INE188A01015
No Notes Added Yet
1. Business Overview
The Fertilisers And Chemicals Travancore Ltd. (FACT) is a pioneering public sector undertaking in India's fertiliser and chemical industry. Its core business involves the manufacturing and marketing of a wide range of fertilisers, including urea and complex fertilisers, primarily for agricultural use. FACT also produces and sells industrial chemicals such as caprolactam (a raw material for nylon-6), anhydrous ammonia, sulphuric acid, and phosphoric acid. The company makes money by selling these products to farmers, industrial clients, and other chemical companies.
2. Key Segments / Revenue Mix
FACT's revenue is primarily derived from two main segments:
Fertilisers: This segment includes the production and sale of Urea (FACT Ujjwala), complex fertilisers like Ammonium Phosphate Sulphate (FACTAMFOS 20:20:0:13), and Ammonium Sulphate. This is the largest revenue contributor, catering directly to the agricultural sector.
Industrial Products: This segment includes products such as Caprolactam, Anhydrous Ammonia, Sulphuric Acid, and Phosphoric Acid, which are sold to various industrial customers.
3. Industry & Positioning
FACT operates in the Indian fertiliser industry, which is highly regulated and strategically important for the country's food security. The industry is characterized by significant government subsidies on fertilisers, raw material import dependency, and susceptibility to monsoon patterns affecting agricultural demand. FACT is one of the oldest and largest public sector fertiliser manufacturers in India, holding a strong market position, especially in the southern states. It competes with other domestic public and private sector players, as well as imported fertilisers.
4. Competitive Advantage (Moat)
FACT's competitive advantages stem from:
Established Brand & History: A long operational history since 1943 has built a recognized brand name, particularly for products like FACTAMFOS, ensuring farmer loyalty in its core markets.
Extensive Distribution Network: A well-developed marketing and distribution network, especially strong in Kerala and other southern states, provides efficient market reach.
Scale of Operations: Operating large-scale manufacturing facilities provides some economies of scale, though these can be offset by older technologies in some units.
Government Ownership: Being a Public Sector Undertaking (PSU) provides a degree of strategic backing and stability, although it can also lead to bureaucratic processes.
5. Growth Drivers
Key factors that can drive FACT's growth over the next 3-5 years include:
Stable Agricultural Demand: Continued population growth and government focus on food security will sustain demand for fertilisers.
Government Support & Subsidies: Ongoing fertiliser subsidy policies are crucial for affordability and demand.
Modernization & Efficiency Improvements: Investment in upgrading existing plants to improve efficiency, reduce energy consumption, and increase output.
Product Diversification/Expansion: Potential for adding new grades of complex fertilisers or expanding capacity for existing products to meet evolving agricultural needs.
Increased Caprolactam Demand: Growth in the synthetic fiber and engineering plastics industry could drive demand for caprolactam.
6. Risks
FACT faces several key risks:
Regulatory & Policy Changes: Changes in government subsidy policies, pricing controls, and import duties can significantly impact profitability.
Raw Material Price Volatility: FACT is reliant on imported raw materials like ammonia, rock phosphate, and sulphur, making it vulnerable to global price fluctuations and foreign exchange rates.
Monsoon Dependency: Agricultural demand for fertilisers is heavily dependent on the success of the monsoon, leading to demand variability.
Environmental Regulations: Stringent environmental norms and compliance costs can impact operational expenses and require significant capital expenditure.
Competition: Intense competition from domestic and international players can put pressure on pricing and market share.
Operational Efficiency: Managing older plants and ensuring continuous modernization can be a challenge.
7. Management & Ownership
FACT is a Public Sector Undertaking (PSU), with the majority ownership resting with the Government of India. The management team is appointed by the government, comprising seasoned professionals, often with extensive experience within the public sector and the fertiliser industry. Strategic decisions are subject to government guidelines and approvals, which can influence long-term planning and capital allocation.
8. Outlook
FACT holds a significant position in the Indian fertiliser landscape, backed by its long history, established brand, and strong regional presence in South India. The inherent demand for fertilisers driven by agricultural needs and continued government support for the sector provide a stable operating environment. However, the company faces structural challenges from volatile raw material prices, regulatory uncertainties surrounding fertiliser subsidies, and the need for continuous modernization in a capital-intensive industry. Its status as a PSU offers stability but can also lead to slower decision-making processes compared to private peers. The company's performance will largely depend on its ability to manage input cost volatility, navigate policy changes, and effectively leverage its operational scale and brand equity to maintain market share.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 1663 | 1097 | 1058 | 600 | 1449 | 949 | 1053 | 1043 | 1629 | 1568 |
| Other Income | 50 | 54 | 54 | 51 | 48 | 57 | 60 | 52 | 51 | 39 |
| Total Income | 1714 | 1151 | 1112 | 651 | 1497 | 1006 | 1113 | 1095 | 1681 | 1607 |
| Total Expenditure | 1531 | 1054 | 1023 | 656 | 1414 | 918 | 968 | 1019 | 1590 | 1611 |
| Operating Profit | 183 | 97 | 89 | -5 | 83 | 89 | 145 | 76 | 91 | -4 |
| Interest | 61 | 62 | 61 | 62 | 61 | 62 | 60 | 62 | 62 | 62 |
| Depreciation | 5 | 5 | 11 | 5 | 6 | 12 | 13 | 7 | 8 | 9 |
| Exceptional Income / Expenses | -11 | 0 | -183 | 8 | -0 | 0 | 16 | 0 | 0 | 0 |
| Profit Before Tax | 105 | 30 | -166 | -64 | 15 | 15 | 88 | 7 | 21 | -74 |
| Provision for Tax | 0 | 0 | -86 | -16 | 4 | 7 | 17 | 3 | 0 | -6 |
| Profit After Tax | 105 | 30 | -79 | -49 | 11 | 8 | 71 | 4 | 21 | -68 |
| Adjustments | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 105 | 30 | -79 | -49 | 11 | 8 | 71 | 4 | 21 | -68 |
| Adjusted Earnings Per Share | 1.6 | 0.5 | -1.2 | -0.8 | 0.2 | 0.1 | 1.1 | 0.1 | 0.3 | -1 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 1981 | 1746 | 1867 | 1927 | 1955 | 2770 | 3259 | 4425 | 6198 | 5051 | 4051 | 5293 |
| Other Income | 49 | 34 | 18 | 45 | 27 | 32 | 80 | 111 | 136 | 217 | 216 | 202 |
| Total Income | 2030 | 1779 | 1885 | 1972 | 1981 | 2802 | 3338 | 4536 | 6334 | 5268 | 4267 | 5496 |
| Total Expenditure | 2185 | 1966 | 1821 | 1762 | 1949 | 2491 | 2720 | 3829 | 5443 | 4707 | 3956 | 5188 |
| Operating Profit | -156 | -187 | 63 | 210 | 32 | 311 | 618 | 707 | 890 | 561 | 311 | 308 |
| Interest | 201 | 261 | 305 | 322 | 281 | 289 | 245 | 244 | 248 | 247 | 246 | 246 |
| Depreciation | 25 | 23 | 21 | 17 | 23 | 18 | 23 | 27 | 30 | 27 | 37 | 37 |
| Exceptional Income / Expenses | 9 | 12 | 0 | 0 | 434 | 972 | 0 | -89 | 0 | -246 | 25 | 16 |
| Profit Before Tax | -373 | -459 | -263 | -129 | 163 | 976 | 350 | 346 | 613 | 42 | 54 | 42 |
| Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -86 | 13 | 14 |
| Profit After Tax | -373 | -459 | -263 | -129 | 163 | 976 | 350 | 346 | 613 | 128 | 41 | 28 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | -373 | -459 | -263 | -129 | 163 | 976 | 350 | 346 | 613 | 128 | 41 | 28 |
| Adjusted Earnings Per Share | -5.8 | -7.1 | -4.1 | -2 | 2.5 | 15.1 | 5.4 | 5.4 | 9.5 | 2 | 0.6 | 0.5 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -20% | -3% | 8% | 7% |
| Operating Profit CAGR | -45% | -24% | 0% | 0% |
| PAT CAGR | -68% | -51% | -47% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -3% | 42% | 47% | 44% |
| ROE Average | 3% | 25% | 44% | 20% |
| ROCE Average | 11% | 20% | 27% | 21% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | -852 | -1310 | -1512 | -1639 | -1472 | -492 | -180 | 662 | 1274 | 1358 | 1371 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 202 | 1668 | 1770 | 1770 | 1796 | 906 | 15 | 10 | 5 | 0 | 0 |
| Other Non-Current Liabilities | 212 | 132 | 128 | 171 | 181 | 200 | 225 | 248 | 231 | 117 | 111 |
| Total Current Liabilities | 2120 | 1194 | 1181 | 1514 | 1810 | 1999 | 3304 | 3819 | 3924 | 4236 | 4426 |
| Total Liabilities | 1682 | 1683 | 1568 | 1816 | 2314 | 2613 | 3364 | 4739 | 5434 | 5711 | 5907 |
| Fixed Assets | 330 | 314 | 297 | 295 | 295 | 257 | 286 | 816 | 814 | 827 | 951 |
| Other Non-Current Assets | 37 | 34 | 79 | 88 | 99 | 159 | 174 | 150 | 361 | 398 | 417 |
| Total Current Assets | 1316 | 1335 | 1192 | 1433 | 1920 | 2156 | 2864 | 3733 | 4219 | 4445 | 4499 |
| Total Assets | 1682 | 1683 | 1568 | 1816 | 2314 | 2613 | 3364 | 4739 | 5434 | 5711 | 5907 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 3 | 38 | 20 | 32 | 46 | 6 | 49 | 179 | 182 | 50 | 436 |
| Cash Flow from Operating Activities | 192 | -237 | 31 | 224 | -410 | 214 | 1021 | 152 | 638 | 280 | 140 |
| Cash Flow from Investing Activities | -9 | -4 | 75 | -3 | 416 | 336 | -854 | -157 | -765 | 213 | -282 |
| Cash Flow from Financing Activities | -181 | 224 | -94 | -207 | -45 | -508 | -36 | 8 | -5 | -107 | -75 |
| Net Cash Inflow / Outflow | 2 | -17 | 12 | 14 | -40 | 42 | 130 | 3 | -132 | 386 | -217 |
| Closing Cash & Cash Equivalent | 5 | 21 | 32 | 46 | 6 | 49 | 179 | 182 | 50 | 436 | 218 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | -5.76 | -7.09 | -4.06 | -1.99 | 2.51 | 15.08 | 5.42 | 5.35 | 9.47 | 1.98 | 0.64 |
| CEPS(Rs) | -5.37 | -6.73 | -3.73 | -1.73 | 2.87 | 15.35 | 5.77 | 5.77 | 9.94 | 2.39 | 1.2 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0.97 | 0.59 |
| Book NAV/Share(Rs) | -13.16 | -20.25 | -23.37 | -25.33 | -22.75 | -7.6 | -2.78 | 10.23 | 19.68 | 20.98 | 21.18 |
| Core EBITDA Margin(%) | -10.04 | -12.33 | 2.32 | 8.25 | 0.28 | 10.05 | 16.54 | 13.47 | 12.18 | 6.81 | 2.34 |
| EBIT Margin(%) | -8.45 | -11.04 | 2.16 | 9.67 | 22.68 | 45.66 | 18.28 | 13.35 | 13.88 | 5.72 | 7.39 |
| Pre Tax Margin(%) | -18.33 | -25.62 | -13.5 | -6.47 | 8.32 | 35.22 | 10.75 | 7.83 | 9.89 | 0.83 | 1.33 |
| PAT Margin (%) | -18.33 | -25.62 | -13.5 | -6.47 | 8.32 | 35.22 | 10.75 | 7.83 | 9.89 | 2.54 | 1.02 |
| Cash Profit Margin (%) | -17.09 | -24.33 | -12.41 | -5.61 | 9.5 | 35.87 | 11.45 | 8.44 | 10.37 | 3.07 | 1.92 |
| ROA(%) | -22.17 | -27.25 | -16.16 | -7.63 | 7.88 | 39.6 | 11.73 | 8.55 | 12.05 | 2.3 | 0.71 |
| ROE(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 143.71 | 63.32 | 9.75 | 3.02 |
| ROCE(%) | -64.33 | -48.61 | 5.85 | 25.24 | 61.53 | 118.74 | 40.53 | 32.91 | 37.62 | 11.02 | 11.3 |
| Receivable days | 1.86 | 2.19 | 48.51 | 79.6 | 71.87 | 52.41 | 27.7 | 11.53 | 19.26 | 23.02 | 19.9 |
| Inventory Days | 99.22 | 96.28 | 76.94 | 83.02 | 105.58 | 80.07 | 60.42 | 48.56 | 48.29 | 76.66 | 94.1 |
| Payable days | 88.12 | 114.5 | 129.47 | 134.38 | 120.84 | 73.05 | 59.72 | 63.49 | 47.33 | 48.23 | 61.14 |
| PER(x) | 0 | 0 | 0 | 0 | 14.54 | 2.14 | 20.25 | 24.48 | 21.67 | 316.69 | 1003.69 |
| Price/Book(x) | -2.13 | -1.04 | -1.77 | -2.02 | -1.61 | -4.25 | -39.44 | 12.81 | 10.43 | 29.92 | 30.19 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.49 | 0.15 | 0.09 |
| EV/Net Sales(x) | 1.44 | 1.81 | 2.7 | 2.86 | 2.34 | 1.16 | 2.22 | 1.79 | 1.97 | 7.77 | 9.85 |
| EV/Core EBITDA(x) | -18.3 | -16.92 | 79.52 | 26.26 | 141.14 | 10.38 | 11.68 | 11.2 | 13.72 | 69.94 | 128.14 |
| Net Sales Growth(%) | 0 | -11.86 | 6.92 | 3.22 | 1.44 | 41.71 | 17.65 | 35.78 | 40.08 | -18.5 | -19.8 |
| EBIT Growth(%) | 0 | -14.92 | 121.25 | 359.55 | 129.71 | 185.38 | -52.9 | -0.83 | 45.63 | -66.44 | 3.64 |
| PAT Growth(%) | 0 | -22.98 | 42.72 | 50.87 | 226.05 | 499.62 | -64.07 | -1.17 | 76.93 | -79.07 | -67.86 |
| EPS Growth(%) | 0 | -22.97 | 42.72 | 50.87 | 226.06 | 499.62 | -64.07 | -1.17 | 76.93 | -79.07 | -67.86 |
| Debt/Equity(x) | -1.31 | -1.42 | -1.59 | -1.39 | -1.54 | -3.7 | -9.95 | 1.99 | 1.04 | 0.95 | 0.94 |
| Current Ratio(x) | 0.62 | 1.12 | 1.01 | 0.95 | 1.06 | 1.08 | 0.87 | 0.98 | 1.08 | 1.05 | 1.02 |
| Quick Ratio(x) | 0.36 | 0.79 | 0.65 | 0.63 | 0.7 | 0.8 | 0.71 | 0.8 | 0.83 | 0.78 | 0.8 |
| Interest Cover(x) | -0.86 | -0.76 | 0.14 | 0.6 | 1.58 | 4.37 | 2.43 | 2.42 | 3.48 | 1.17 | 1.22 |
| Total Debt/Mcap(x) | 0.62 | 1.36 | 0.9 | 0.69 | 0.96 | 0.87 | 0.25 | 0.16 | 0.1 | 0.03 | 0.03 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 |
| FII | 0.11 | 0.11 | 0.12 | 0.07 | 0.1 | 0.14 | 0.2 | 0.21 | 0.21 | 0.21 |
| DII | 8.99 | 9.01 | 9 | 9 | 9.01 | 8.99 | 9.01 | 9.01 | 9.01 | 9.02 |
| Public | 0.9 | 0.89 | 0.88 | 0.93 | 0.89 | 0.87 | 0.79 | 0.78 | 0.78 | 0.77 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 58.24 | 58.24 | 58.24 | 58.24 | 58.24 | 58.24 | 58.24 | 58.24 | 58.24 | 58.24 |
| FII | 0.07 | 0.07 | 0.08 | 0.04 | 0.06 | 0.09 | 0.13 | 0.14 | 0.13 | 0.14 |
| DII | 5.82 | 5.83 | 5.82 | 5.82 | 5.83 | 5.82 | 5.83 | 5.83 | 5.83 | 5.84 |
| Public | 0.58 | 0.57 | 0.57 | 0.6 | 0.58 | 0.56 | 0.51 | 0.5 | 0.5 | 0.5 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 64.71 | 64.71 | 64.71 | 64.71 | 64.71 | 64.71 | 64.71 | 64.71 | 64.71 | 64.71 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 |
| FII | 0.11 | 0.11 | 0.12 | 0.07 | 0.1 | 0.14 | 0.2 | 0.21 | 0.21 | 0.21 |
| DII | 8.99 | 9.01 | 9 | 9 | 9.01 | 8.99 | 9.01 | 9.01 | 9.01 | 9.02 |
| Public | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 58.24 | 58.24 | 58.24 | 58.24 | 58.24 | 58.24 | 58.24 | 58.24 | 58.24 | 58.24 |
| FII | 0.07 | 0.07 | 0.08 | 0.04 | 0.06 | 0.09 | 0.13 | 0.14 | 0.13 | 0.14 |
| DII | 5.82 | 5.83 | 5.82 | 5.82 | 5.83 | 5.82 | 5.83 | 5.83 | 5.83 | 5.84 |
| Public | 6.47 | 6.47 | 6.47 | 6.47 | 6.47 | 6.47 | 6.47 | 6.47 | 6.47 | 6.47 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 64.71 | 64.71 | 64.71 | 64.71 | 64.71 | 64.71 | 64.71 | 64.71 | 64.71 | 64.71 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -20% | -3% | +8% | +7% |
| Operating Profit CAGR | -45% | -24% | 0% | — |
| PAT CAGR | -68% | -51% | -47% | — |
| Share Price CAGR | -3% | +42% | +47% | +44% |
| ROE Average | +3% | +25% | +44% | +20% |
| ROCE Average | +11% | +20% | +27% | +21% |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.